TAPIMMUNE INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by TAPIMMUNE INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D/A2024-05-17New Enterprise Associates 16, L.P.Marker Therapeutics, Inc.1,071,42812.0%EDGAR
SC 13D/A2023-03-03Aisling Capital IV, LPMarker Therapeutics, Inc.464,2855.5%EDGAR
SC 13D/A2021-03-26New Enterprise Associates 16, L.P.Marker Therapeutics, Inc.14,464,28517.4%EDGAR
SC 13D/A2021-03-24Leen Ann M.Marker Therapeutics, Inc.2,415,8422.9%EDGAR
SC 13D/A2021-03-15Eastern Capital LTDMarker Therapeutics, Inc.3,966,6685.0%EDGAR
SC 13D/A2020-11-13Eastern Capital LTDMarker Therapeutics, Inc.4,466,6689.2%EDGAR
SC 13D/A2020-06-18Eastern Capital LTDMarker Therapeutics, Inc.4,883,33510.3%EDGAR
SC 13D/A2020-02-20Eastern Capital LTDMarker Therapeutics, Inc.5,300,00211.2%EDGAR
SC 13G/A2020-02-14PERCEPTIVE ADVISORS LLCMarker Therapeutics, Inc.00.0%EDGAR
SC 13D2019-02-14Wilson John RobertMarker Therapeutics, Inc.8,261,85317.4%EDGAR
SC 13D2019-02-14Leen Ann M.Marker Therapeutics, Inc.2,715,8425.9%EDGAR
SC 13D2019-02-14Vera JuanMarker Therapeutics, Inc.2,715,8425.9%EDGAR
SC 13G2019-02-14PERCEPTIVE ADVISORS LLCMarker Therapeutics, Inc.3,500,0007.5%EDGAR
SC 13G/A2019-02-04Brio Capital Master Fund Ltd.Marker Therapeutics, Inc.237,4960.1%EDGAR
SC 13D/A2018-11-08Eastern Capital LTDMarker Therapeutics, Inc.5,300,00211.3%EDGAR
SC 13D2018-10-25New Enterprise Associates 16, L.P.Marker Therapeutics, Inc.8,750,00017.8%EDGAR
SC 13D2018-10-19Aisling Capital IV, LPMarker Therapeutics, Inc.3,500,0007.7%EDGAR
SC 13D/A2018-05-16Eastern Capital LTDTAPIMMUNE INC.5,300,00238.8%EDGAR
SC 13D2018-04-04Iroquois Capital Management, LLCTAPIMMUNE INC.382,7545.5%EDGAR
SC 13G/A2018-02-14Iroquois Capital Management, LLCTAPIMMUNE INC.382,7545.5%EDGAR